Abstract:Abstract Background Endoscopic submucosal dissection (ESD) is an advanced luminal resection technique for dysplastic and early cancerous gastrointestinal (GI) tract neoplasms. By removing lesions en bloc, this method provides more accurate histopathologic evaluation of resection margins in comparison to endoscopic mucosal resection (EMR). Superior curative resection and lower recurrence rates over EMR have been shown in addition to the benefit of reduced morbidity and mortality compared to surgery. While ESD has become well-established in Asia and Europe, its adoption in North America – and in particular Canada – has been slowed by multiple technical and economic factors including a scarcity of infrastructure, institutional support, and standardized training. Additionally, reproduced Canadian data corroborating its known global efficacy is currently lacking. Aims Our aim was to evaluate clinical and technical outcomes in patients who underwent ESD of superficial GI tract neoplasms at a tertiary-care academic centre. Methods We conducted a retrospective single-centre cohort study at The Centre for Advanced Therapeutic Endoscopy & Endoscopic Oncology, St. Michael’s Hospital, Toronto, Canada. Consecutive adults (age ampersand:003E 18) who underwent ESD of any superficial GI tract neoplasm from October 2017 to December 2022 were included in the study. Primary outcomes were rates of en bloc, complete (R0), and curative resections. Secondary outcomes were rates of recurrence and adverse events. Data was collected through electronic chart review. Results ESD was performed in a total of 308 lesions with a mean size of 2.5 cm (range, 1-7 cm). Gastric ESD was the most common (n=130), followed by esophageal (n=91), rectal (n=62), and colonic (n=22). Three patients underwent duodenal ESD. En bloc, R0, and curative resection rates were 89.2%, 84.7%, and 71.8%, respectively. 64.3% of lesions were cancerous on pathology (n=198), of which 48 had at least submucosal invasion. Rates of delayed bleeding and deep mural injury (DMI) requiring surgical intervention were 3.9% and 1.3%, respectively. Overall recurrence at the first surveillance endoscopy (SE1) was 3.6%. Conclusions En bloc, R0, and curative resection rates reported from this largest single-centre Canadian ESD cohort are comparable to existing North American data. Low rates of early recurrence and an adequate safety profile have been demonstrated with this emerging oncologic method of resection. Additional investigation is warranted to optimize lesion selection and determine long-term clinical outcomes to further establish this technique in the management of superficial GI tract neoplasms. Table I. Procedural characteristics, outcomes, and adverse events for patients who underwent ESD of superficial GI tract neoplasms. Funding Agencies None

Endoscopic Submucosal Multi-Tunnel Dissection for Circumferential Superficial Esophageal Neoplastic Lesions (with Videos)

Endoscopic Submucosal Dissection for the Treatment of Large Gastric Submucosal Tumors Originating from the Muscularis Propria Layer: a Single Center Study.

Effects Analysis of Endoscopic Submucosal Tunnel Dissection in Treatment of Upper Gastrointestinal Tumor

Clinical benefit of tunnel endoscopic submucosal dissection for esophageal squamous cancer: a multicenter, randomized controlled trial

A129 OUTCOMES FOLLOWING ENDOSCOPIC SUBMUCOSAL DISSECTION OF SUPERFICIAL GASTROINTESTINAL TRACT NEOPLASTIC LESIONS FROM A TERTIARY-CARE ACADEMIC CENTRE

Endoscopic Submucosal Dissection for Superficial Proximal Esophageal Neoplasia is Highly Successful.

Endoscopic Submucosal Dissection for Giant Esophageal Lipomatous Tumors

Comparison of Short-Term Efficacy Between Endoscopic Submucosal Tunnel Dissection and Endoscopic Submucosal Dissection in Treatment of Wide Esophageal Squamous Cell Carcinoma of Early Stage.

Endoscopic Submucosal Dissection for Treatment of Esophageal Submucosal Tumors Originating from the Muscularis Propria Layer

Endoscopic Submucosal Dissection for Early Esophageal Carcinomas and Pre-Malignant Lesions

Clinical Outcomes of Endoscopic Submucosal Dissection for Laterally Spreading Tumors Involving the Dentate Line

Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma.

Submucosal Tunnel Endoscopic Resection for Extraluminal Tumors: a Novel Endoscopic Method for En Bloc Resection of Predominant Extraluminal Growing Subepithelial Tumors or Extra-Gastrointestinal Tumors (with Videos)

Endoscopic Submucosal Dissection for Esophageal Lesions

Endoscopic transmural route for dissection of gastric submucosal tumors with extraluminal growth: experience in two cases

Efficacy and safety of endoscopic submucosal tunnel dissection vs endoscopic submucosal dissection for early superficial upper gastrointestinal precancerous lesions and tumors: A meta‐analysis

Submucosal Tunneling Endoscopic Resection Vs Thoracoscopic Enucleation for Large Submucosal Tumors in the Esophagus and the Esophagogastric Junction.

Endoscopic Submucosal Dissection in Upper Gastrointestinal Lesions

Evaluation of endoscopic submucosal dissection for early esophageal cancers and precancerous lesion

Endoscopic Submucosal Dissection for Colorectal Epithelial Neoplasm

Feasibility and safety of endoscopic full‐thickness resection for submucosal tumors in the upper gastrointestinal tract, including predominantly extraluminal submucosal tumors (with video)